More an more patients are being treated for mild/ moderate depression with #antidepressants in general practice, despite there being very poor evidence for efficacy. In my experience, some people experience a transient benefit between 4&12 weeks (likely placebo mediated) &
This transient (non specific) effect of taking antidepressants gradually wears off. Patients present back to their GP with similar symptoms or a variant of the same symptoms & most GPS simply up the dose, meanwhile none or little of the psychosocial distress is being addressed.
Many ppl then become psychologically & physically dependent on higher doses of antidepressants with risk of side effects & withdrawal effects accumulating. Often a significant % of these patients barely meet the criteria for what we call depression & even if they do...
The distress of a]the depressed person is typically due/ related to to accumulated stress, lack of sleep, loneliness, trauma, poverty/ financial strain, relationship breakdown, bereavement, chronic pain etc, GPS have little or no time to meaningfully address any of the above
& with little support or knowledge of alternatives up until now, as well as prescribing for distress becoming more culturally normal, GPs& patients find ourselves in a very dysfunctional situation, no one really knowing where to turn to. Pharmaceutical companies have profited
No doubt for some ppl the specific drug induced effect of antidepressants is helpful, but I wonder what % of ppl this truly the case with real world long term trials e.g. Star D showing a 4% remission rate at 1 year. This thread is not about pill shaming, it’s about creating
Honest transparent dialogue as there is so much misleading information that has had an enormous momentum in overmedicalising distress. There are effective alternatives IMO, but what is most important at this stage is to recognise the flaws in our current ways of dealing with
Human distress & creating dialogue, research & openness to effective alternatives both individually & collectively. I see the effects of this misinformation & poorly thought out systematic approach in practice daily & it frustrates & saddens me.

• • •

Missing some Tweet in this thread? You can try to force a refresh
 

Keep Current with Dr Bryan McElroy

Dr Bryan McElroy Profile picture

Stay in touch and get notified when new unrolls are available from this author!

Read all threads

This Thread may be Removed Anytime!

PDF

Twitter may remove this content at anytime! Save it as PDF for later use!

Try unrolling a thread yourself!

how to unroll video
  1. Follow @ThreadReaderApp to mention us!

  2. From a Twitter thread mention us with a keyword "unroll"
@threadreaderapp unroll

Practice here first or read more on our help page!

More from @BryanMcElroy8

16 Jan
Further reflections & learning points from last nights expert panel discussion:

Withdrawal from psychotropic medications is a multifaceted, complex process - never do so cold turkey & try your utmost to find a dr to work with you with an open, flexible, slow tapering approach
2/ The importance of accurate language:

‘Discontinuation syndrome’ was a term coined by pharmaceutical companies in an effort to address (cover over) the issue of withdrawal effects & dependency forming nature that antidepressants can have in up to 50% of people.
3/ Social prescribing is a very valid alternative to prescribing an antidepressant and is gaining momentum in the UK.

Gardening, outdoor or social activities can renew self esteem & lift low mood.

Informed consent means educating people regarding a range of alternatives.
Read 7 tweets

Did Thread Reader help you today?

Support us! We are indie developers!


This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3/month or $30/year) and get exclusive features!

Become Premium

Too expensive? Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal Become our Patreon

Thank you for your support!

Follow Us on Twitter!